ELUT Elutia Inc.

Elutia Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

CHIEF FINANCIAL OFFICER Ferguson Matthew converted options into 12,500 shares and covered exercise/tax liability with 4,461 shares, increasing direct ownership by 2% to 350,417 units (SEC Form 4)
4 - ELUTIA INC. (0001708527) (Issuer)
6/12/25 5:00:16 PM ET
$ELUT
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
PRESIDENT AND CEO Mills C Randal converted options into 27,084 shares and covered exercise/tax liability with 9,664 shares, increasing direct ownership by 6% to 306,713 units (SEC Form 4)
4 - ELUTIA INC. (0001708527) (Issuer)
6/12/25 5:00:09 PM ET
$ELUT
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
CHIEF SCIENTIFIC OFFICER Williams Michelle Leroux converted options into 12,500 shares and covered exercise/tax liability with 3,951 shares, increasing direct ownership by 11% to 84,835 units (SEC Form 4)
4 - ELUTIA INC. (0001708527) (Issuer)
6/12/25 5:00:07 PM ET
$ELUT
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
SEC Form 4 filed by Director Jordan Maybelle
4 - ELUTIA INC. (0001708527) (Issuer)
6/2/25 5:00:14 PM ET
$ELUT
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
SEC Form 4 filed by Director Zuga Matt
4 - ELUTIA INC. (0001708527) (Issuer)
6/2/25 5:00:12 PM ET
$ELUT
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
SEC Form 4 filed by Director Rakin Kevin
4 - ELUTIA INC. (0001708527) (Issuer)
6/2/25 5:00:14 PM ET
$ELUT
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
SEC Form 4 filed by Director Colpman David
4 - ELUTIA INC. (0001708527) (Issuer)
6/2/25 5:00:10 PM ET
$ELUT
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
SEC Form 4 filed by Director Makes Brigid
4 - ELUTIA INC. (0001708527) (Issuer)
6/2/25 5:00:09 PM ET
$ELUT
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Director Highcape Capital, L.P. bought $1,050,000 worth of shares (420,000 units at $2.50) (SEC Form 4)
4 - ELUTIA INC. (0001708527) (Issuer)
3/13/25 4:30:13 PM ET
$ELUT
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Director Highcape Capital, L.P. bought $1,050,000 worth of shares (420,000 units at $2.50) (SEC Form 4)
4 - ELUTIA INC. (0001708527) (Issuer)
3/13/25 4:28:27 PM ET
$ELUT
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care

Elutia Inc.

Recent Analyst Ratings for Elutia Inc.

Elutia Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

CHIEF FINANCIAL OFFICER Ferguson Matthew converted options into 12,500 shares and covered exercise/tax liability with 4,461 shares, increasing direct ownership by 2% to 350,417 units (SEC Form 4)

PRESIDENT AND CEO Mills C Randal converted options into 27,084 shares and covered exercise/tax liability with 9,664 shares, increasing direct ownership by 6% to 306,713 units (SEC Form 4)

CHIEF SCIENTIFIC OFFICER Williams Michelle Leroux converted options into 12,500 shares and covered exercise/tax liability with 3,951 shares, increasing direct ownership by 11% to 84,835 units (SEC Form 4)

SEC Form 4 filed by Director Jordan Maybelle

SEC Form 4 filed by Director Zuga Matt

SEC Form 4 filed by Director Rakin Kevin

SEC Form 4 filed by Director Colpman David

SEC Form 4 filed by Director Makes Brigid

Director Highcape Capital, L.P. bought $1,050,000 worth of shares (420,000 units at $2.50) (SEC Form 4)

Director Highcape Capital, L.P. bought $1,050,000 worth of shares (420,000 units at $2.50) (SEC Form 4)